SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010449
Filing Date
2020-08-12
Accepted
2020-08-12 17:27:06
Documents
69
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q hepa-20200630x10q.htm 10-Q 1257381
2 EX-31.1 hepa-20200630ex31134cbda.htm EX-31.1 10845
3 EX-31.2 hepa-20200630ex31233a606.htm EX-31.2 10031
4 EX-32.1 hepa-20200630ex321cba7bf.htm EX-32.1 5845
5 EX-32.2 hepa-20200630ex3226e08b6.htm EX-32.2 5530
6 GRAPHIC hepa-20200630x10q002.jpg GRAPHIC 4347
  Complete submission text file 0001558370-20-010449.txt   6128277

Data Files

Seq Description Document Type Size
7 EX-101.INS hepa-20200630.xml EX-101.INS 1397820
8 EX-101.SCH hepa-20200630.xsd EX-101.SCH 44288
9 EX-101.CAL hepa-20200630_cal.xml EX-101.CAL 38359
10 EX-101.DEF hepa-20200630_def.xml EX-101.DEF 205818
11 EX-101.LAB hepa-20200630_lab.xml EX-101.LAB 426652
12 EX-101.PRE hepa-20200630_pre.xml EX-101.PRE 336249
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36856 | Film No.: 201096302
SIC: 2834 Pharmaceutical Preparations